← Evidence map

ReviewMolecular biology reports2025

Targeting the undruggable MYC in cancer: the rationale of using XPO1 inhibitors.

Leonidas Benetatos et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40214838